Life-threatening diffuse alveolar hemorrhage associated with Rhinovirus infection and the potential role of corticosteroids in immunocompetent patients

RATIONALE: Diffuse alveolar hemorrhage (DAH) is a rare but potentially fatal condition characterized by bleeding into alveolar spaces, most often associated with autoimmune disease or severe infection. Rhinovirus is a common cause of upper respiratory tract infection but is rarely associated with DAH in immunocompetent individuals. We report 2 cases of life-threatening DAH associated with rhinovirus infection, both presenting with severe hypoxemia and showing marked improvement following corticosteroid therapy. PATIENT CONCERNS: Case 1: An 85-year-old woman presented with massive hemoptysis, dyspnea, and hypoxemia. Chest computed tomography (CT) revealed diffuse ground-glass opacities (GGOs) and patchy consolidations. Case 2: A 70-year-old woman developed worsening dyspnea and hemoptysis despite antibiotics. She was hypoxemic, and chest CT showed bilateral GGOs and consolidations. DIAGNOSES: Bronchoalveolar lavage fluid demonstrated progressively hemorrhagic aliquots consistent with DAH in both cases. Multiplex viral polymerase chain reaction identified rhinovirus as the sole pathogen in both cases, and autoimmune serologic tests were negative. INTERVENTIONS: Both patients received high-flow oxygen therapy, empirical antibiotics, and systemic corticosteroids (Case 1: intravenous methylprednisolone 1 mg/kg/day; Case 2: intravenous methylprednisolone 500 mg/day for 3 days, followed by tapering). OUTCOMES: After corticosteroid therapy, both patients showed rapid clinical and radiographic improvement, with resolution of hypoxemia and discharge within 10 days. LESSONS: These cases suggest a potential association between rhinovirus infection and life-threatening DAH in immunocompetent patients. Both patients showed marked clinical improvement after corticosteroid therapy, suggesting a potential therapeutic role for systemic corticosteroids. Thus, clinicians should consider rhinovirus infection as a possible infectious trigger of DAH, and systemic corticosteroids may be considered in selected severe cases.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-10-16
DOI
https://doi.org/10.1097/md.0000000000051157
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Life-threatening diffuse alveolar hemorrhage associated with Rhinovirus infection and the potential role of corticosteroids in immunocompetent patients

Yu‐Il Kim, Yong Soo Kwon, Bo‐Gun Kho, Joon‐Young Yoon et al.
Medicine
Respiratory viral infections research
article

Life-threatening diffuse alveolar hemorrhage associated with Rhinovirus infection and the potential role of corticosteroids in immunocompetent patients

Yu‐Il Kim, Yong Soo Kwon, Bo‐Gun Kho, Joon‐Young Yoon, Hong‐Joon Shin, Sung‐Chul Lim, Chang-Seok Yoon, Tae-Ok Kim
article en

Abstract

RATIONALE: Diffuse alveolar hemorrhage (DAH) is a rare but potentially fatal condition characterized by bleeding into alveolar spaces, most often associated with autoimmune disease or severe infection. Rhinovirus is a common cause of upper respiratory tract infection but is rarely associated with DAH in immunocompetent individuals. We report 2 cases of life-threatening DAH associated with rhinovirus infection, both presenting with severe hypoxemia and showing marked improvement following corticosteroid therapy. PATIENT CONCERNS: Case 1: An 85-year-old woman presented with massive hemoptysis, dyspnea, and hypoxemia. Chest computed tomography (CT) revealed diffuse ground-glass opacities (GGOs) and patchy consolidations. Case 2: A 70-year-old woman developed worsening dyspnea and hemoptysis despite antibiotics. She was hypoxemic, and chest CT showed bilateral GGOs and consolidations. DIAGNOSES: Bronchoalveolar lavage fluid demonstrated progressively hemorrhagic aliquots consistent with DAH in both cases. Multiplex viral polymerase chain reaction identified rhinovirus as the sole pathogen in both cases, and autoimmune serologic tests were negative. INTERVENTIONS: Both patients received high-flow oxygen therapy, empirical antibiotics, and systemic corticosteroids (Case 1: intravenous methylprednisolone 1 mg/kg/day; Case 2: intravenous methylprednisolone 500 mg/day for 3 days, followed by tapering). OUTCOMES: After corticosteroid therapy, both patients showed rapid clinical and radiographic improvement, with resolution of hypoxemia and discharge within 10 days. LESSONS: These cases suggest a potential association between rhinovirus infection and life-threatening DAH in immunocompetent patients. Both patients showed marked clinical improvement after corticosteroid therapy, suggesting a potential therapeutic role for systemic corticosteroids. Thus, clinicians should consider rhinovirus infection as a possible infectious trigger of DAH, and systemic corticosteroids may be considered in selected severe cases.

MedicineVol. 105(42)
Chonnam National University (KR), Chonnam National University Hospital (KR)
Good health and well-being
Openalex Percentile: Top 12%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.